미생물 동정 시장 : 제품 및 서비스별, 방법별, 용도별, 최종 용도별 - 세계 예측(2024-2032년)

Microbial Identification Market size is projected to record 8.8% CAGR from 2024 to 2032, driven by increasing collaboration and partnerships alongside technological advancements in identification techniques. Researchers and companies are forging alliances to enhance research capabilities and expand application areas. Technological innovations, such as genomics and bioinformatics are also improving the accuracy and speed of microbial identification processes.

Growing advancements are further facilitating quicker responses to emerging pathogens and improving diagnostic precision in various industries, including healthcare, agriculture, and environmental monitoring. For instance, in April 2023, JMI Laboratories and bioMerieux partnered for antimicrobial resistance diagnostics for leveraging expertise in microbial identification. This collaboration helped in advancing diagnostic capabilities and addressing evolving challenges in microbial resistance globally.

The overall market is segregated into product and services, method, application, end-use, and region.

In terms of product and services, the instruments segment in the microbial identification market is expected to record significant CAGR from 2024 to 2032, propelled by advances in cutting-edge technologies like genomics and spectroscopy. Instruments help in enhancing accuracy and efficiency in identifying microorganisms across various sectors from healthcare to agriculture. Developments, such as integration of AI and automation to streamline processes and improve diagnostic speed are also enabling quicker responses to the emerging pathogens and facilitating personalized treatment strategies, adding to the segment growth.

By application, the microbial identification industry from the pharmaceuticals segment is projected to rise from 2024 to 2032. This is driven hefty investments by pharmaceutical companies on advanced microbial identification technologies to ensure product safety and efficacy. Molecular biology techniques and mass spectrometry are improving the accuracy and speed of microbial identification in drug development and manufacturing processes. Pharmaceuticals are also optimizing quality control measures and regulatory compliance in bioinformatics and data analytics for proactive management of microbial risks.

Regionally, the Asia Pacific microbial identification market size is projected to exhibit robust growth between 2024 and 2032, fueled by increasing attention on enhancing food safety and expanding healthcare infrastructure. Advanced technologies, such as PCR and MALDI-TOF are widely adopted to ensure precise microbial identification in both food and clinical applications. Investments in healthcare facilities are bolstering the efforts for providing broader access to advanced diagnostic tools and strengthening regional healthcare systems, further driving the industry expansion in APAC.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of infectious diseases
    • 3.2.1.2 Rising technological advancements
    • 3.2.1.3 Increasing awareness about food safety
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of automated microbial identification systems
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product and Services, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Instruments
  • 5.2.1 Mass spectrometers
  • 5.2.2 PCR systems
  • 5.2.3 Microarrays
  • 5.2.4 Other instruments
• 5.3 Consumables
  • 5.3.1 Reagents and kits
  • 5.3.2 Plates and media
• 5.4 Software
• 5.5 Services

Chapter 6 Market Estimates and Forecast, By Method, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Phenotypic methods
• 6.3 Genotypic methods
• 6.4 Proteotypic methods

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Clinical diagnostics
• 7.3 Pharmaceuticals
• 7.4 Cosmetic and personal care product testing
• 7.5 Food and beverage testing
• 7.6 Environmental application
• 7.7 Other applications

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Pharmaceutical and biotechnology companies
• 8.3 Hospitals and diagnostic laboratories
• 8.4 Food testing laboratories
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Avantor, Inc.
• 10.2 bioMérieux SA
• 10.3 Becton, Dickinson and Company
• 10.4 Bruker Corporation
• 10.5 Beckman Coulter, Inc.
• 10.6 Biolog, Inc.
• 10.7 Charles River Laboratories International, Inc.
• 10.8 Eurofins Scientific
• 10.9 Merck KGaA
• 10.10 Qiagen N.V.
• 10.11 Shimadzu Corporation
• 10.12 Thermo Fisher Scientific Inc.
• 10.13 Wickham Micro Limited